Donald E Frail

Title: The Innovative Contributions of Donald E. Frail

Introduction

Donald E. Frail is a notable inventor based in Laguna Hills, CA (US). He has made significant contributions to the field of biotechnology, particularly in skin rejuvenation. His work has implications for both cosmetic applications and medical treatments.

Latest Patents

Donald E. Frail holds a patent for "Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation." This innovative polypeptide has an amino acid sequence corresponding to a binding domain of a botulinum toxin. It modulates the expression of genes involved in collagen production and extracellular matrix organization. This modulation enhances skin quality attributes such as elasticity and firmness. Additionally, the polypeptide inhibits lipogenesis in specialized cells, which helps reduce skin oiliness, a common issue in skin tissue afflicted with large pores and acne. The patent also describes nucleic acids encoding the polypeptide, as well as vectors, host cells, and systems comprising these nucleic acids.

Career Highlights

Donald E. Frail is associated with Allergan, Inc., a company renowned for its advancements in medical aesthetics and pharmaceuticals. His work at Allergan has allowed him to contribute to innovative solutions in skin care and rejuvenation.

Collaborations

Some of his notable coworkers include Birgitte P. S. Jacky and Amy Brideau-Andersen. Their collaborative efforts have likely enhanced the research and development of Frail's innovative projects.

Conclusion

Donald E. Frail's contributions to the field of biotechnology, particularly through his patent on botulinum toxin polypeptides, showcase his commitment to advancing skin rejuvenation techniques. His work continues to influence both cosmetic and medical fields, highlighting the importance of innovation in improving skin health.